Part D Rx Use Shows “Little Change” As Enrollees Enter Coverage Gap, CMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
CMS gives first glimpse at the kind of Part D drug claims data that will become available to researchers in December.
You may also be interested in...
Nearly A Quarter Of Diabetes Patients Altered Therapy In Part D Gap – Study
Twenty-three percent of a large sample of Medicare Part D enrollees taking oral drugs for diabetes changed their medication use when they reached the gap in coverage, according to a study released by the Kaiser Family Foundation Aug. 21
Part D Drug Data Expected To Be Available For Research Dec. 1
CMS is targeting Dec. 1 as the date for opening Medicare Part D drug claims data to both government and independent researchers
GSK's Nucala Is Significantly Overpriced, ICER Draft Report Finds
New biologic for severe asthma doesn't stack up well to standard of care on generally accepted levels of cost per quality-adjusted life year.